Your Location:
Home >
Browse articles >
Mechanisms of Shenqi Wenfei Prescription in Intervening in Chronic Obstructive Pulmonary Disease in Rats Based on ROS/TXNIP/NLRP3 Signaling Pathway
Updated:2026-01-07
    • Mechanisms of Shenqi Wenfei Prescription in Intervening in Chronic Obstructive Pulmonary Disease in Rats Based on ROS/TXNIP/NLRP3 Signaling Pathway

    • “The latest research has found that Shenqi Wenfei Formula can significantly improve lung function and reduce inflammatory response in rats with chronic obstructive pulmonary disease, possibly by regulating the ROS/TXNIP/NLRP3 pathway to inhibit cell pyroptosis.”
    • WU Di , SHI Mengyao , ZHANG Lu , LIU Tong , TONG Jiabing , YANG Cheng , LI Zegeng
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 3, Pages: 78-87(2026)
    • DOI: 10.13422/j.cnki.syfjx.20251236     

      CLC:
    • Revised:2025-06-04 ,

      Accepted:09 June 2025 ,

    Scan QR Code

  •  
  •  
  • AI Introduction

  • Full Text(HTML)

  • Figs( 6 ) Tabs( 8 )

  • References

  • Publication Info

  • Metrics

306

Views

262

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Etiology, Pathogenesis, Syndrome Differentiation and Treatment Rules of Chronic Obstructive Pulmonary Disease in Traditional Chinese Medicine
Application and Prospect of State-target Pattern Differentiation and Treatment Theory in Signaling Pathways of Chronic Obstructive Pulmonary Disease
Mechanism of Qiju Dihuang Wan in Treatment of Diabetic Retinopathy Based on NLRP3/Caspase-1/GSDMD Signaling Pathway
Tianxiang Pills Alleviates Myocardial Cell Pyroptosis in Rat Model of Myocardial Ischemia/Reperfusion Injury by Inhibiting Oxidative Stress via ROS/Caspase-1/GSDMD Signaling Pathway
Clinical Efficacy of Modified Linggui Zhugan Tang in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome of Spleen Deficiency and Dampness Obstruction with Blood Stasis Type and Its Effect on MIF, miR-223, and IL-18

Related Author

WU Di
SHI Mengyao
ZHANG Lu
LIU Tong
TONG Jiabing
YANG Cheng
LI Zegeng
YANG Qinjun

Related Institution

Institute of Traditional Chinese Medicine Respiratory Disease Prevention and Treatment,Anhui Academy of Chinese Medicine
Anhui Key Laboratory of Applied Transformation of Traditional Chinese Medicine in the Prevention and Treatment of Major Pulmonary Diseases
School of Traditional Chinese Medicine(TCM), Anhui University of Chinese Medicine
Anhui Provincial Key Laboratory for the Application and Transformation of TCM in the Prevention and Treatment of Major Pulmonary Diseases
Gansu University of Chinese Medicine